EBIT (Earnings Before Interest & Tax) for the period was £4.91m compared to £3.580m in the previous 12-month period, showing an increase of 31%. The numbers have been consolidated from accounts covering the company’s operations across Europe, the US and Asia.
Commenting on the performance, Nicola Burns (Global Managing Director) said: “We invested in a number of initiatives in the previous financial year to ensure our business remained competitive in the fast-changing environment. It was fantastic to achieve the return on this investment with such a strong set of results. Our exhibition offering added considerable revenue across our global operations and the commercial development of SPARK THINKING has helped us enhance and diversify our creative service offering. As a result, our US headquarters have just moved into new office space to ensure we have an inspiring and motivating environment for our talented staff to be their best.”
Burns concluded: “The market continues to evolve and we are developing and investing in integrated apps, systems and software solutions to help meet the changing needs of our pharmaceutical and life science clients. This includes supporting transfer of value reporting requirements and strategic meetings management implementation. The recent collaborative development of the Science Of Meetings approach with our colleagues in the wider Ashfield division has been well received by our clients. In an increasingly regulated environment, it is allowing us to act as a strategic partner to clients and explore multichannel opportunities that offer new types of value for their healthcare professional communication and event strategies.”